MedTrace Logo

A Clinical Trial to Evaluate the Safety and Effectiveness of MatrixOssTM Bone Graft

NCT05371535 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 188

Last updated 2022-05-12

No results posted yet for this study

Summary

The objective of this clinical trial is to evaluate the efficacy and safety of MatrixOssTM Bone Graft in bone defect repair caused by tooth extraction.

Conditions

  • Dental Diseases

Interventions

DEVICE

MatrixOssTM Bone Graft plus Bio-Gide membrane

To verify the efficacy and safety of MatrixOssTM Bone Graft developed and manufactured by Collagen Matrix, Inc. for bone defect repair caused by tooth extraction.

Sponsors & Collaborators

  • Collagen Matrix

    lead INDUSTRY

Principal Investigators

  • Dr. Jian Pan · West China Stomatological Hospital of Sichuan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-30
Primary Completion
2022-11-30
Completion
2023-06-30
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05371535 on ClinicalTrials.gov